414 related articles for article (PubMed ID: 15347303)
1. Helicobacter pylori and nonmalignant diseases.
Kuipers EJ; Malfertheiner P
Helicobacter; 2004; 9 Suppl 1():29-34. PubMed ID: 15347303
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
Gisbert JP; Pajares JM; Losa C
Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
[TBL] [Abstract][Full Text] [Related]
5. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Vergara M; Catalán M; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
[TBL] [Abstract][Full Text] [Related]
7. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and non-malignant diseases.
Kupcinskas L; Malfertheiner P
Helicobacter; 2005; 10 Suppl 1():26-33. PubMed ID: 16178968
[TBL] [Abstract][Full Text] [Related]
9. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
10. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori and non-malignant diseases.
Furuta T; Delchier JC
Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and non-malignant diseases.
Matysiak-Budnik T; Laszewicz W; Lamarque D; Chaussade S
Helicobacter; 2006 Oct; 11 Suppl 1():27-31. PubMed ID: 16925608
[TBL] [Abstract][Full Text] [Related]
13. [Does H. pylori infection or its eradication play a role in gastroeosphageal reflux disease?].
Zerbib F
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):427-31. PubMed ID: 12700499
[TBL] [Abstract][Full Text] [Related]
14. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
Shimada T; Yamagata M; Hiraishi H
Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531
[TBL] [Abstract][Full Text] [Related]
15. [Peptic ulcer, Helicobacter pylori].
Bauerfeind P; Wirth HP
Ther Umsch; 1997 Nov; 54(11):624-8. PubMed ID: 9454363
[TBL] [Abstract][Full Text] [Related]
16. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
18. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
Kiltz U; Zochling J; Schmidt WE; Braun J
Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642
[TBL] [Abstract][Full Text] [Related]
19. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]